What price ranges are disclosed for Zhenyu Xu’s SOPHiA GENETICS (SOPH) share sales?

The filing notes sales at prices ranging from $4.79 to $4.92 per share in one set of trades, and from $4.61 to $4.87 per share in another. The reported per-share prices are weighted averages across these price ranges.

Tax-related sale: SOPHiA GENETICS SA (SOPH) CSO disposes 4,736 shares under 10b5-1 plan

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

SOPHiA GENETICS SA Chief Scientific Officer Zhenyu Xu sold 4,736 Ordinary Shares of SOPH in open-market transactions. The sales occurred on April 8 and 9, 2026 at weighted average prices of about $4.84 and $4.74 per share.

According to the disclosure, these shares were sold to cover tax withholding obligations from restricted stock units that vested on April 2 and 3, 2026. The transactions were executed under a pre-established Rule 10b5-1 trading plan and are described as non-discretionary. After the sales, Xu directly held 640,216 Ordinary Shares.

Insider Trade Summary 10b5-1

Net Seller: 4,736 shares ($22,726)

Net Sell 2 txns

Insider Xu Zhenyu

Role Chief Scientific Officer

Sold 4,736 shs ($23K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	1,936	$4.7399	$9K
Sale	Ordinary Shares	2,800	$4.839	$14K

Holdings After Transaction: Ordinary Shares — 640,216 shares (Direct)

Footnotes (1)

Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. prices ranging from $4.79 to $4.92, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold April 8, 2026: 2,800 shares at $4.8390 Shares sold April 9, 2026: 1,936 shares at $4.7399 Total shares sold: 4,736 shares +3 more

6 metrics

Shares sold April 8, 2026 2,800 shares at $4.8390 Open-market sale of Ordinary Shares

Shares sold April 9, 2026 1,936 shares at $4.7399 Open-market sale of Ordinary Shares

Total shares sold 4,736 shares Net-sell across two transactions

Holdings after April 9 sale 640,216 shares Direct ownership following transactions

Price range footnote F2 $4.79–$4.92 Multiple transactions within this range

Price range footnote F3 $4.61–$4.87 Multiple transactions within this range

Key Terms

Rule 10b5-1 trading plan, restricted stock units, weighted average price, tax withholding obligations

4 terms

Rule 10b5-1 trading plan financial

"These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

restricted stock units financial

"tax withholding obligations arising in connection with the vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

tax withholding obligations financial

"sold by the Reporting Person in the open market to satisfy tax withholding obligations"

Form 4 Insider Transactions: What Each Field Means →

04/10/2026 - 04:02 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Xu Zhenyu

(Last)

(First)

(Middle)

C/O SOPHIA GENETICS SA

LA PIECE 12

(Street)

ROLLE

1180

(City)

(State)

(Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Scientific Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	04/08/2026		S		2,800⁽¹⁾	D	$4.839⁽²⁾	642,152	D
Ordinary Shares	04/09/2026		S		1,936⁽¹⁾	D	$4.7399⁽³⁾	640,216	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

2. prices ranging from $4.79 to $4.92, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Elimara Brunetto as Attorney-in-fact for Zhenyu Xu	04/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did SOPHiA GENETICS (SOPH) insider Zhenyu Xu report in this Form 4?

Zhenyu Xu reported selling 4,736 Ordinary Shares of SOPHiA GENETICS SA. The transactions were open-market sales tied to tax withholding on vested restricted stock units and executed under a pre-established Rule 10b5-1 trading plan.

How many SOPHiA GENETICS (SOPH) shares did Zhenyu Xu sell and at what prices?

Zhenyu Xu sold 2,800 shares at a weighted average price of $4.8390 and 1,936 shares at a weighted average price of $4.7399. In total, 4,736 Ordinary Shares were sold across the two reported transactions.

Why were SOPHiA GENETICS (SOPH) shares sold by Zhenyu Xu in this filing?

The filing states the shares were sold to satisfy tax withholding obligations arising from the vesting of restricted stock units on April 2 and 3, 2026. The sales are characterized as tax-related rather than discretionary trading activity.

Were the SOPHiA GENETICS (SOPH) insider sales made under a Rule 10b5-1 plan?

Yes. The disclosure explains that the sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by Zhenyu Xu. The filing notes these do not represent discretionary trades, indicating they were pre-planned transactions.

How many SOPHiA GENETICS (SOPH) shares does Zhenyu Xu hold after these transactions?

After the reported sales, Zhenyu Xu directly owned 640,216 Ordinary Shares of SOPHiA GENETICS SA. This figure reflects his remaining direct holdings following the 4,736 shares sold for tax withholding purposes in the two reported transactions.